echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > PNAS identifies potential therapeutic window for ALS

    PNAS identifies potential therapeutic window for ALS

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The team believes that astrocytes are closely related to the death of motor neurons


    "We think this is very important because astrocyte dysfunction is active after ALS patients develop symptoms," said Nicholas Malagakis, MD, PhD, Johns Hopkins Medicine Professor of Neurology and Medical Director of the Johns Hopkins ALS Clinical Trials Unit


    In the study, published March 21 in PNAS, the researchers analyzed brain and spinal cord tissue from ALS patients and observed that a specific astrocyte protein, connexin 43, acts as an open pore that sends toxic factors from astrocytes to motor neurons


    The research team was also able to grow stem cell lines from ALS patients and grow them into astrocytes


    Malagakis said: "This is a new pathway that we have shown to exist in ALS tissue, animal models and patient-derived stem cells


    Malagakis said drugs are being developed that can block this hemichannel


    Malagakis said the study provides growing evidence that astrocytes play a role in the spread of ALS


    Akshata A.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.